MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) Operating cash flow 2016–2025
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$7.0MFY2025 · since FY2016: -$6.1M → -$7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.0M | +55.9% |
| FY2024 | -$15.9M | -4.0% |
| FY2023 | -$15.3M | +20.2% |
| FY2022 | -$19.2M | -25.8% |
| FY2021 | -$15.2M | +12.3% |
| FY2020 | -$17.4M | -23.2% |
| FY2019 | -$14.1M | -36.5% |
| FY2018 | -$10.3M | +9.9% |
| FY2017 | -$11.5M | -87.3% |
| FY2016 | -$6.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MTNB financial trends
MTNB RevenueMTNB Net incomeMTNB Net marginMTNB Gross profitMTNB Gross marginMTNB Operating incomeMTNB Operating marginMTNB Free cash flowMTNB Capital expendituresMTNB Return on equityMTNB Stock buybacksMTNB Dividends paidMTNB Total assetsMTNB Total liabilitiesMTNB Shareholders’ equityMTNB overview →